COMPARATIVE ANALYSIS OF DRUG EFFICACY IN THE TREATMENT FOR COVID-19 SEVERE FORMS, BASED ON ATTRIBUTE-BASED STATISTIC METHODS AND ANALYSIS OF DRUG INTERACTIONS
Severe and critical forms of COVID-19 are beset by the development of “a cytokine storm”, which is characterized by an increased secretion of proinflammatory cytokines. Therefore, one of the leading strategies for treating patients with severe forms of COVID-19 is the reduction of concentration of p...
Saved in:
Main Authors: | O. V. Zhukova, I. N. Kagramanyan, A. L. Khokhlov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute
2021-03-01
|
Series: | Фармация и фармакология (Пятигорск) |
Subjects: | |
Online Access: | https://www.pharmpharm.ru/jour/article/view/739 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atherosclerosis and Inflammation: Are the Rules of the Game Changing with Biological Therapies?
by: Bora R, et al.
Published: (2025-07-01) -
Efficiency of il-6 inhibitor (olokizumab) in suppressing inflammation in patients with moderate COVID-19 pneumonia
by: N. G. Ganyukova, et al.
Published: (2020-12-01) -
Innate immune role of IL-6 in influenza a virus pathogenesis
by: Xinxin Li, et al.
Published: (2025-07-01) -
EXPERIENCE OF USING DRUG TOCILIZUMAB IN A BOY WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: E. S. Zholobova, et al.
Published: (2013-11-01) -
A case of effective use of interleukin 6 inhibitors in patients with ankylosing spondylitis with secondary amyloidosis
by: Sh. F. Erdes, et al.
Published: (2021-08-01)